Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics

Neuroscience

Volumn 84, Issue 4, 1998, Pages 1187-1196

  Ozaki, T ^a   Katsumoto, E ^a   Mui, K ^a   Furutsuka, D ^a   Yamagami, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AP 1; Fos related protein; Immunocytochemistry; Jun related protein; Neuroleptics; Super gel shift assay

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; ONCOPROTEIN; PROTEIN C FOS; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; GENE INDUCTION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; PYRIFORM CORTEX;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; MALE; MICE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SULPIRIDE; TRANSCRIPTION FACTOR AP-1;

EID: 0031967959     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00536-8     Document Type: Article

References (45)

1. 1. Angel P., Hattori K., Smeal T. and Karin M. (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875-885.
2. 2. Arai R., Kimura H. and Maeda T. (1986) Topographic atlas of monoamine oxidase-containing neurons in the rat brain studied by an improved histochemical method. Neuroscience 19, 905-925.
3. 3. Asher P. and Nowak L. (1988) The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurons in culture. J. Physiol., Lond. 399, 247-266.
4. 4. Chiu R., Angel P. and Karin M. (1989) JunB differs in its biological properties from and is a negative regulator of c-Jun. Cell 59, 979-986.
5. 5. Cowad D. M. (1992) General pharmacology of clozapine. Br. J. Psychiat. 160 Suppl., 5-11.
6. 6. Deutch A. Y., Öngür D. and Duman R. S. (1995) Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action. Neuroscience 66, 337-346.
7. 7. Di Chiara G., Morelli M. and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions. Trends Neurosci. 17, 228-233.
8. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37, 287-294.
9. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Archs gen. Psychiat. 49, 538.
10. 10. Freyd G., Kim S. K. and Horvitz H. R. (1990) Novel cystein-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene Un-U‡. Nature 344, 876-879.
11. 11. Galizzi J.-P., Fosset M. and Ronney G. (1986) Neuroleptics of the diphenylbutyl-piperidine series are potent calcium channel inhibitors. Proc. natn. Acad. Sci. U.S.A. 83, 7513-7517.
12. 1-containing neurons. J. Neurosci. 15, 8167-8176.
13. 13. Gould R. J., Murphy K. M. M. and Reynolds I. J. (1983) Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. natn. Acad. Sci. U.S.A. 80, 5122-5125.
14. 14. Guo N., Robertson G. S. and Fibiger H. C. (1992) Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588, 164-167.
15. 15. Henry B. S. and Michael Z. G. (1993) Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 362, 79-83.
16. 16. Iino M., Ozawa S. and Tsuzuki K. (1990) Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurons. J. Physiol., Lond. 424, 151-165.
17. 17. Ingraham H. A., Flynn S. E., Voss J. W., Albert V. R., Kapiloff M. S., Wilson L. and Rosenfeld M. G. (1990) The POU-specific domain of Pit-1 is essential for sequence specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61, 1021-1033.
18. 18. Kerppola T. K. and Curran T. (1991) Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 66, 317-326.
19. 19. Konradi C. and Heckers S. (1995) Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience 65, 1051-1061.
20. 20. Konradi C., Leveque J.-C. and Hyman S. E. (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16, 4231-4239.
21. 21. Lee W., Mitchel P. and Tjian R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
22. 22. Lerea L. S., Butler L. S. and McNamara J. O. (1992) NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons; involves calcium influx via different routes. J. Neurosci. 12, 2973-2981.
23. 23. Leysen J. E. and Niemegeers C. J. E. (1985) Neuroleptics. Handbook of Neurochemistry (ed. Lajtha A.), Vol. 31, p. 331. Plenum, New York.
24. 23a. Lowry O. H., Rosenbrough H. J., Farr A. L. and Randall R. J. (1951) Protein measurements with the Folin phenol reagent. J. biol. Chem. 193, 265-275.
25. 24. MacDermott A. B., Mayer M. L., Westbrook G. L., Smith S. J. and Barker J. L. (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321, 519-522.
26. 1A receptors in human brain tissue. Eur. J. Pharmac. 221, 397-398.
27. 26. Miller J. C. (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54, 1453-1455.
28. 27. Morgan J. I. and Curran C. W. (1986) Role of ion flux in the control of c-fos expression. Nature 322, 552-555.
29. 28. Nakabeppu Y., Nathans D. (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64, 751-759.
30. 29. Nakamura S., Akiguchi I. and Kimura J. A. (1993) A subpopulation of mouse striatal cholinergic neurons show monoamine oxidase activity. Neurosci. Lett. 161, 141-144.
31. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am. J. Psychiat. 152, 1444-1449.
32. 31. Ogata N., Yoshii M. and Narahashi T. (1989) Psychotropic drugs block voltage-gated ion channels in neuroblastoma cells. Brain Res. 476, 140-144.
33. 32. Ozaki T., Katsumoto E., Yokotani N. and Yamagami S. (1997) The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity. Eur. Neuropsychopharmac. 73, 181-187.
34. 33. Pickar D. (1995) Prospects for pharmacotherapy of schizophrenia. Lancet 345, 557-562.
35. 34. Rauscher F. J. III, Sambucetti L. C., Curran T., Distel R. J. and Spiegelman B. M. (1988) Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell 52, 471-480.
36. 35. Robertson G. S. and Fibiger H. C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46, 315-328.
37. 36. Robertson G. S., Matsumura H. and Fibiger H. C. (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmac. exp. Ther. 271, 1058-1066.
38. 2 receptor antagonists induce immediate early genes in the rat striatum. Brain Res. Bull. 29, 469-472.
39. 38. Sassone-Corci P., Sisson J. C. and Verna I. (1988) Transcriptional autoregulation of the proto-oncogene fos. Nature 334, 319-329.
40. 39. Saucer R. T. (1990) Scissors and helical forks. Nature 347, 514-515.
41. 40. Schreiber E., Matthias P., Muller M. M. and Schaffer W. (1989) Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
42. 41. Schroth G. P., Cook G. R., Eradbury E. M. and Gottesfel J. M. (1989) Transcription factor III A induced bending of the Xenopus somatic 5S gene promoter. Nature 340, 487-488.
43. 2 receptor antagonist, Neuroscience 62, 407-423.
44. 43. Sonnenberg J. L., Mitchelmore C., Macgregor-Leon P. F., Hempstead J., Morgan J. I. and Curran T. (1989) Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24, 72-80.
45. 44. Van Beveren C., Van Straaten F. and Curran T. (1983) Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 34, 865-879.